Nasal Drug Delivery Technology Market Surpass $68.1 Billion By 2026 | CAGR 7.3%

Author: Acumen Research and Consulting

Acumen Research and Consulting has published a new report titled "Nasal Drug Delivery Technology Market (By Dosage Form: Spray, Drops, Gel, Powder; By Container Type: Pressurized, Non-pressurized; By Therapeutic Application: Nasal Congestion, Rhinitis, Asthma, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026". The worldwide nasal drug delivery technology market size is expected to touch valuation around USD 68.1 billion by 2026, this market is foreseen to develop with 7.3% CAGR during the forecast time period.

Expanding inclination for elective method of medication organization is one of the main considerations expected to fuel the market development amid the estimate time frame. Developing frequency of chronic diseases is likewise expected to add to the market extension over the coming years.

As per an examination distributed in Research and Development (RAND) Review blog in 2017, around 60% of American grown-ups have somewhere around one chronic condition, which results in colossal going through on human services each year. Also, almost 30 million Americans live with five ceaseless conditions or more. Moreover, commercialization of novel products and nearness of strongerproduct pipeline are foreseen to help the market development. For example, Eli Lilly and Company built up a helpful splash (intranasal glucagon) for the treatment of blood sugar.

Download Report Sample Pages For Better Understanding@ 

The product is under survey and expected to be endorsed by 2019 in the U.S. Also, Europe regions. Furthermore, NATESTO, created by Endo Pharmaceuticals Inc., got endorsement in 2014 for Testosterone Replacement Therapy (TRT) and was marketed in 2015. The product is the sole gel directed on the eye for TRT in male grown-ups determined to have hypogonadism. Besides, rising patient inclination for nasal products inferable from expanded mindfulness about these products alongside their adequacy and simple organization properties is foreseen to fuel the market development.

Also, nasal drug delivery systems offers benefits, for example, non-invasiveness and decrease in slack time caused because of oral medication conveyance. These favourable circumstances help in giving better patient solace, which thusly, enhances their adherence for the medicine. As per an examination driven by Binghamton University, State University at New York, in August 2018, Narcan (naloxone), a solitary advance nasal spray, is the most straightforward product to convey.

The global nasal drug delivery technology market is segmented into dosage form, container type, therapeutic application and region.On the basis dosage form, the global nasal drug delivery technology market is segmented into spray, drops, gel, and powder. On the basis container type, the global nasal drug delivery technology market is segmented into pressurized and non-pressurized. On the basis therapeutic application, the global nasal drug delivery technology market is segmented into nasal congestion, rhinitis, asthma, and others. On the basis of region the global nasal drug delivery technology market is bifurcated into Europe, Latin America, North America, Middle East & Africa, and Asia Pacific.

North America drove the market with an income offer of 36.41% in 2018. This development was ascribed to expanded malady pervasiveness combined with purchaser mindfulness about nasal products. As per CDC, in 2017, the quantity of grown-ups with asthma matured 18 years or more in U.S. were around 20.4 million contributing roughly 8.3% of the all-out populace in the nation. In addition, the quantity of kids under 18 years old with asthma was around 6.1 million. North America will observer stronger development throughout the following couple of years because of created economies in the region.

Asia Pacific is relied upon to witness the quickest CAGR of 7.5% in the coming years. This development is for the most part because of accessibility of viable treatment strategies, high neglected clinical requirements, rising disposable income, and expanding mindfulness about these products. Also, the nearness of key organizations in this region, for example, AptarGroup, Inc.; Sun Pharmaceutical Industries Ltd.; and Cipla Inc., is required to positively affect the general market.


The worldwide business is probably going to confront serious challenge over the conjecture time frame attributable to the nearness of global organizations. Topographical extension, new item advancement, and joint endeavours are a portion of the key methodologies attempted by key market players. For example, in 2016, OptiNose, Inc. declared pipeline undertaking to screen nose-to-mind application, which is subsidized by Research Council of Norway for treating narcolepsy of Orexin-A utilizing OptiNose Bi-Directional Breath Powered delivery technology.

Some of the main key players associated with the nasal drug delivery technology market are NAVEH Pharma Ltd.; GlaxoSmithKline PLC; ENT Technologies Pty. Ltd.; AstraZeneca PLC; Douglas Pharmaceuticals Ltd.; Pfizer, Inc.; PendoPharm, Inc.; OptiNose, Inc.; B.F. Ascher& Company, Inc.; Becton, Dickinson and Company; Cadila Pharmaceuticals Ltd.; and Promius Pharma, LLC.


The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report - 

Would like to place an order or any question, please feel free to contact at